Cargando…
A robust signature of immune‐related long non‐coding RNA to predict the prognosis of bladder cancer
BACKGROUND: Bladder cancer is the second most common malignant tumor in the urogenital system. The research investigated the prognostic role of immune‐related long non‐coding RNA (lncRNA) in bladder cancer. METHODS: We extracted 411 bladder cancer samples from The Cancer Genome Atlas database. Singl...
Autores principales: | Lai, Cong, Wu, Zhenyu, Li, Zhuohang, Yu, Hao, Li, Kuiqing, Tang, Zhuang, Liu, Cheng, Xu, Kewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446409/ https://www.ncbi.nlm.nih.gov/pubmed/34374227 http://dx.doi.org/10.1002/cam4.4167 |
Ejemplares similares
-
A robust immune-related lncRNA signature for the prognosis of human colorectal cancer
por: Zhu, Gongmin, et al.
Publicado: (2022) -
An epithelial–mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer
por: Tong, Hang, et al.
Publicado: (2021) -
Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
por: Zhang, Yichi, et al.
Publicado: (2022) -
An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
por: Zhu, Rui, et al.
Publicado: (2019) -
Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung
por: Miao, Huikai, et al.
Publicado: (2021)